Image
Malaysian Health Technology Assessment Section (MaHTAS)
is tasked to provide evidence-based input on health technology and clinical practice.

Image

Latest fromMaHTAS

Image
Image


AskCPG is your new AI-powered clinical assistant!

Good news, everyone!

Tired of digging through 200-page CPG PDFs during rounds? Stop scrolling and start healing.

AskCPG is your new AI-powered clinical assistant, designed to give you precise, evidence-based answers for your clinical practice in seconds, thus no manual searching required.

Rest assured, every piece of info is rooted from our evidence-based Clinical Practice Guidelines developed by MaHTAS. Trusted science, proven results.

How to get started:

1. Access the platform: Access it via the MaHTAS official portal.

2. Ask your question: Type your clinical query in plain language (e.g., "What is the management protocol for dengue with warning signs?").

3. Get cited answers: Receive a concise, structured response with direct links back to the official CPG source.

This platform is built for the Malaysian Frontliner.

A huge shoutout to the team at QMed for developing this intuitive system. By collaborating with MaHTAS, they’ve made clinical guidelines faster, smarter, and easier to use at the point of care.

Image

HTA Presentation of Evidence Table: National Screening Programme for Prostate Cancer
Date: 28 September 2026

The Evidence Table presentation on “National Screening Programme for Prostate Cancer” was chaired by the Deputy Director of MaHTAS, Dr. Syaqirah Akmal, with participation from a multidisciplinary panel of experts in Urology, Pathology, Radiology, Public Health and Health Economics. The session reviewed evidence on the effectiveness, safety and cost-effectiveness of a risk-stratified national screening programme compared with opportunistic screening in Malaysia, including its potential implications for clinical practice and healthcare resources. The discussion provided valuable expert insights to support a rigorous, evidence-based and contextually relevant health technology assessment.

Image


Accelerating Healthcare Transformation: From Vision to Solutions
Date: 23 September 2026

MaHTAS officers from the Health Industry Development Unit attended the INTEL & MRANTI Healthcare Transformation event at Le Méridien Kuala Lumpur, which explored the role of digital transformation and AI in improving healthcare delivery. The session highlighted AI applications in diagnostics, clinical decision-making, patient monitoring and healthcare operations, alongside key considerations on regulation, cybersecurity, SaMD and clinical evidence. The event also showcased innovative AI-enabled healthcare solutions and provided insights into MRANTI’s Health Tech Hub initiatives.

Image


MaHTAS Co-Host GIN Conference 2026
Date: 15–18 September 2026

MaHTAS participated in the GIN 2026 Conference held from 15–18 September at the Kuala Lumpur Convention Centre (KLCC), bringing together healthcare leaders, guideline developers and researchers from around the world. Key highlights included the MaHTAS-hosted Welcome Reception, discussions on AI in guideline development, planetary health and high-value care, and knowledge-sharing on guideline implementation and clinical audit indicators. The conference also provided opportunities for regional collaboration with the Agency for Care Effectiveness (ACE), Singapore, and strengthened connections within the global guideline development community.

Image
Centre of Informed Decision Making in Malaysia
"Is it safe? Is it effective? Is it cost-effective"

MaHTAS is responsible in assessing health technologies and advocating evidence-informed decision-making for better health care.

MaHTAS conduct horizon scanning, health technology assessment (HTA), develop and implement Clinical Practice Guidelines (CPG).

Image

Follow our Facebook for more updates on MaHTAS